DHR

Investigation Alert BAX, DHR, BTAI, and IBRX: Johnson Fistel, LLP Encourages Long-Term Investors to Submit Their Information Below

Retrieved on: 
Tuesday, September 26, 2023
GMP, LLP, Institutional review board, Good manufacturing practice, Baxter International, CMOS, Record, DHR, Research, Danaher Corporation, Complaint, Dementia, Patient, FDA, Therapy, BLA, NYSE, Agitation, Food, Safety, Pharmaceutical industry, Management

Defendants’ failure to disclose Baxter’s true problems relating to its supply chain deceived investors about the Company’s true financial health and earnings.

Key Points: 
  • Defendants’ failure to disclose Baxter’s true problems relating to its supply chain deceived investors about the Company’s true financial health and earnings.
  • Johnson Fistel, LLP is investigating potential claims on behalf of Danaher Corporation (NYSE: DHR) against certain of its officers and directors.
  • Johnson Fistel, LLP is investigating potential claims on behalf of BioXcel Therapeutics, Inc. (NASDAQ: BTAI) against certain of its officers and directors.
  • Johnson Fistel, LLP is investigating potential claims on behalf of ImmunityBio, Inc. (NASDAQ: IBRX) against certain of its officers and directors.

Danaher to Provide Cepheid's Tuberculosis Test to the Global Fund at Cost

Retrieved on: 
Tuesday, September 19, 2023
Partnership, The Global Fund to Fight AIDS, Tuberculosis and Malaria, Bill & Melinda Gates Foundation, TB, Danaher, DHR, Infection, Research, International development, Danaher Corporation, Mark R. Dybul, Incidence, AIDS, Patient, Tuberculosis, United, Stop TB Partnership, USAID, NYSE, World Health Organization, Pharmaceutical industry, Video game, Unitaid, Malaria, Cepheid variable

Enables the Global Fund to provide Cepheid's Xpert® MTB/RIF Ultra diagnostic test cartridges for TB at cost, with no profit to Danaher.

Key Points: 
  • Enables the Global Fund to provide Cepheid's Xpert® MTB/RIF Ultra diagnostic test cartridges for TB at cost, with no profit to Danaher.
  • WASHINGTON, Sept. 19, 2023 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) ("Danaher"), a global science and technology innovator, today announced it will provide Cepheid's Xpert® MTB/RIF Ultra diagnostic test cartridges for tuberculosis (TB) at Cepheid's cost of $7.97 each to the Global Fund to Fight AIDS, TB and Malaria ("the Global Fund") and to less-developed countries eligible for Cepheid's Global Access Program1 to support greater access to high-quality TB testing.
  • By reducing the price of Cepheid's Xpert® MTB/RIF Ultra test cartridge to $7.97, Danaher will be selling at its cost and will earn no profit.
  • The agreement significantly expands a longtime partnership between Cepheid - a Danaher operating company - and the Global Fund to improve access to testing where it matters most.

DHR FINAL DEADLINE TOMORROW: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Danaher Corporation Investors to Secure Counsel Before Important September 15 Deadline in Securities Class Action – DHR

Retrieved on: 
Thursday, September 14, 2023
Titan, Class, COVID-19, DHR, Danaher Corporation, Advertising, Court, Growth, NYSE, I-Space (Chinese company), Insurance, Tobacco

WHAT TO DO NEXT: To join the Danaher class action, go to https://rosenlegal.com/submit-form/?case_id=17717 or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join the Danaher class action, go to https://rosenlegal.com/submit-form/?case_id=17717 or call Phillip Kim, Esq.
  • If you wish to serve as lead plaintiff, you must move the Court no later than September 15, 2023.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

SHAREHOLDER ALERT: The Law Offices of Vincent Wong Remind Danaher Investors of a Lead Plaintiff Deadline of September 15, 2023

Retrieved on: 
Thursday, September 14, 2023
Danaher Corporation, Vincent Wong, Law, DHR, NYSE

NEW YORK, Sept. 14, 2023 (GLOBE NEWSWIRE) -- Attention Danaher Corporation ("Danaher") (NYSE: DHR) shareholders:

Key Points: 
  • NEW YORK, Sept. 14, 2023 (GLOBE NEWSWIRE) -- Attention Danaher Corporation ("Danaher") (NYSE: DHR) shareholders:
    The Law Offices of Vincent Wong announce that a class action lawsuit has commenced on behalf of investors who purchased between April 21, 2022 and April 24, 2023.
  • If you suffered a loss on your investment in Danaher, contact us about potential recovery by using the link below.
  • There is no cost or obligation to you.

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Danaher Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 15, 2023 – (NYSE: DHR)

Retrieved on: 
Wednesday, September 13, 2023
Danaher Corporation, NEXT, COVID-19, Danaher, Growth, Fraud, DHR, Holding company, Security (finance)

NEW YORK, Sept. 13, 2023 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Danaher Corporation.

Key Points: 
  • NEW YORK, Sept. 13, 2023 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Danaher Corporation.
  • Shareholders who purchased shares of DHR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
  • DEADLINE: September 15, 2023 Shareholders should not delay in registering for this class action.
  • The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Danaher, Sea, and Syneos and Encourages Investors to Contact the Firm

Retrieved on: 
Tuesday, September 12, 2023
Vaccine, Workforce, P.C, Biotechnology, ADS, COVID-19, DHR, Research, Danaher Corporation, Sea Ltd, Projection, Risk, III, Biophysical environment, SE, Growth, Data, News, NYSE, Radiometer (company), Pharmaceutical industry, Audit, Cryptocurrency, Diagnosis, Sea, Syneos Health

The Company is comprised of more than 20 operating companies organized under four segments: Biotechnology; Life Sciences; Diagnostics; and Environmental & Applied Solutions.

Key Points: 
  • The Company is comprised of more than 20 operating companies organized under four segments: Biotechnology; Life Sciences; Diagnostics; and Environmental & Applied Solutions.
  • In 2020 and 2021, Danaher's diagnostic tests and life sciences research tools were widely used in the effort to combat the COVID-19 virus.
  • As a result, Danaher experienced a significant upswing in revenue growth over the course of this period.
  • On this news, the price of Syneos common stock fell more than 46%, further damaging investors.

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Hostess Brands, Inc. (Nasdaq – TWNK), Avantax, Inc. (Nasdaq – AVTA), Thorne HealthTech, Inc. (Nasdaq - THRN), Abcam plc (Nasdaq - ABCM)

Retrieved on: 
Monday, September 11, 2023
Agreement, Cetera Financial Group, Tripura Merger Agreement, Brodsky, SJM, The J.M. Smucker Company, Danaher, Cetara, DHR, Hostess, Danaher Corporation, NYSE, Security (finance), Abcam

If you own shares and wish to discuss the investigation, contact Jason Brodsky ( [email protected] ) or Marc Ackerman ( [email protected] ) at 855-576-4847.

Key Points: 
  • If you own shares and wish to discuss the investigation, contact Jason Brodsky ( [email protected] ) or Marc Ackerman ( [email protected] ) at 855-576-4847.
  • Under the terms of the merger agreement, Hostess shareholders will receive $30.00 in cash and 0.03002 shares of The J.M.
  • Smucker Co. common stock (valued at $4.25 as of September 8, 2023) for each share of Hostess common stock.
  • Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits.

SHAREHOLDER ALERT: Levi & Korsinsky Notifies Danaher Corporation (DHR) Investors of a Class Action Lawsuit and Upcoming Deadline

Retrieved on: 
Monday, September 11, 2023
CASE, LLP, Telephone, COST, COVID-19, DHR, Danaher Corporation, Levi, The Company, CLASS, NEXT, Court, Growth, NYSE, Cryptocurrency

NEW YORK, Sept. 11, 2023 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Danaher Corporation ("Danaher" or the "Company") (NYSE: DHR) of a class action securities lawsuit.

Key Points: 
  • NEW YORK, Sept. 11, 2023 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Danaher Corporation ("Danaher" or the "Company") (NYSE: DHR) of a class action securities lawsuit.
  • CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Danaher investors who were adversely affected by alleged securities fraud between April 21, 2022 and April 24, 2023.
  • Follow the link below to get more information and be contacted by a member of our team:
    DHR investors may also contact Joseph E. Levi, Esq.
  • For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services’ Top 50 Report as one of the top securities litigation firms in the United States.

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Danaher Corporation of Class Action Lawsuit and Upcoming Deadline – DHR

Retrieved on: 
Saturday, September 9, 2023
Vaccine, LLP, Biotechnology, COVID-19, Danaher, DHR, Research, Person, Danaher Corporation, Projection, Ext, SEC Rule 10b-5, District court, Action Replay, Complaint, Cepheid variable, Biophysical environment, Court, Growth, Pomerantz, NYSE, News, Pharmaceutical industry, Diagnosis

NEW YORK, Sept. 09, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Danaher Corporation (“Danaher” or the “Company”) (NYSE: DHR), and certain officers.

Key Points: 
  • NEW YORK, Sept. 09, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Danaher Corporation (“Danaher” or the “Company”) (NYSE: DHR), and certain officers.
  • To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.
  • The Firm has recovered billions of dollars in damages awards on behalf of class members.

Danaher Corporation: Please contact the Portnoy Law Firm to recover your losses; September 15, 2023 deadline

Retrieved on: 
Friday, September 8, 2023
Danaher Corporation, Projection, COVID-19, Danaher, DHR, NYSE, News, Pharmaceutical industry, Cryptocurrency

LOS ANGELES, Sept. 08, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Danaher Corporation (“Danaher” or the “Company”) (NYSE: DHR) investors that a lawsuit filed on behalf of investors that purchased Danaher securities between April 21, 2022, and April 24, 2023, both dates inclusive (the “Class Period”).

Key Points: 
  • Investors are encouraged to contact attorney Lesley F. Portnoy , by phone 844-767-8529 or email : [email protected], to discuss their legal rights, or click here to join the case via www.portnoylaw.com .
  • The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors’ options for pursuing claims to recover their losses.
  • On April 25, 2023, Danaher issued a press release announcing its financial results for the first quarter of 2023.
  • The Portnoy Law Firm represents investors in pursuing claims against caused by corporate wrongdoing.